|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Terumo Corporation, a leading manufacturer of single-use medical devices, such as syringes, blood bags and IV solutions. |
|---|---|
| Transferring Party | MicroVention, Inc., a developer of catheter-based technologies for the endovascular treatment of cerebral and peripheral vascular diseases. |
| Sector | Medical Devices |
| Date | February 28, 2006 |
| Analysis Enables Terumo to expand into the growing worldwide market for the endovascular treatment of cerebral aneurysms. Terms not disclosed. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |